Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

Proteome Analysis

Below the proteome analysis is presented. The analysis methods are presented in the paper Propagating Differential Gene Expression in Protein Interaction Networks. If you are interested in the most reliable results choose the

  • value_type as 'ranked' since this provides a very robust analysis method.
  • intercation map as 'high confidence'
  • network_comparison type as 'Divided' since this leads to a natural grouping of similar proteins
  • filtered as 'true' since this will only use the microarray measurements that have a sufficiently large confidence level.

  • Navigation/Query Panel:
    Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
    Rank Gene Hugo description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
    Results: HTML CSV LaTeX Showing element 527 to 576 of 3228 in total
    Value Type: Ranked
    Network Comparison Type: Divided
    Interaction Map: High confidence
    Filtered: 1
    \def\wcA{0.14285714285714\textwidth} \def\wcB{0.14285714285714\textwidth} \def\wcC{0.14285714285714\textwidth} \def\wcD{0.14285714285714\textwidth} \def\wcE{0.14285714285714\textwidth} \def\wcF{0.14285714285714\textwidth} \begin{longtable}{|c|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent 527\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent DDX31\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent dead (asp-glu-ala-asp) box polypeptide 31 isoform 1; dead/dexh helicase ddx31. [source:refseq;acc:nm\_022779]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 248.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 232.579\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06871\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 528\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent YME1L1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent yme1-like 1 isoform 3; atp-dependent metalloprotease ftsh1 homolog. [source:refseq;acc:nm\_014263]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 222.146\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 237.393\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06864\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 529\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent DDX18\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent atp-dependent rna helicase ddx18 (dead-box protein 18) (myc-regulated dead-box protein) (mrdb). [source:swissprot;acc:q9nvp1]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 251.653\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 235.506\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06856\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 530\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent LSM6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent u6 snrna-associated sm-like protein lsm6 (sm protein f). [source:swissprot;acc:q9y4y8]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 227.483\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 212.994\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06803\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 531\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent PRPF19\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent nuclear matrix protein nmp200 related to splicing factor prp19. [source:refseq;acc:nm\_014502]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 223.356\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 209.149\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06793\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 532\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ZNF622\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent zinc finger-like protein 9. [source:refseq;acc:nm\_033414]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 250.942\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 235.004\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.06782\vspace{3pt}}}\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 533\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent SLC45A2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent membrane-associated transporter protein (aim-1 protein) (melanoma antigen aim1). [source:swissprot;acc:q9umx9]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 534\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent guanine nucleotide-binding protein-like 1 (gtp-binding protein hsr1). [source:swissprot;acc:p36915]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 535\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent POLR2H\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent dna-directed rna polymerases i, ii, and iii 17.1 kda polypeptide (ec 2.7.7.6) (rpb17) (rpb8) (rpabc3). [source:swissprot;acc:p52434]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 236.662\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 252.708\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.0678\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 536\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent SSB\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent lupus la protein (sjogren syndrome type b antigen) (ss-b) (la ribonucleoprotein) (la autoantigen). [source:swissprot;acc:p05455]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 242.531\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 227.136\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06778\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 537\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent DHX15\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent putative pre-mrna splicing factor rna helicase (deah box protein 15) (atp-dependent rna helicase #46). [source:swissprot;acc:o43143]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 229.803\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 215.301\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06736\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 538\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent POLR2L\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent dna-directed rna polymerase ii 7.6 kda polypeptide (ec 2.7.7.6) (rpb10) (rpb7.6) (rpabc5). [source:swissprot;acc:p52436]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 237.627\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 253.604\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06724\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 539\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent MEMO1P\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent protein cgi-27 (c21orf19-like protein). [source:swissprot;acc:q9y316]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 236.964\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 252.86\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06708\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 540\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent SEPHS2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent selenide,water dikinase 2 (ec 2.7.9.3) (selenophosphate synthetase 2) (selenium donor protein 2). [source:swissprot;acc:q99611]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 222.156\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 208.201\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.06703\vspace{3pt}}}\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 541\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent MICAL2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent flavoprotein oxidoreductase mical2. [source:refseq;acc:nm\_014632]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 542\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent INPP4B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent inositol polyphosphate-4-phosphatase, type ii, 105kd; inositol polyphosphate 4-phosphatase ii; 4-phosphatase ii. [source:refseq;acc:nm\_003866]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 543\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent SEPHS1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent selenide,water dikinase 1 (ec 2.7.9.3) (selenophosphate synthetase 1) (selenium donor protein 1). [source:swissprot;acc:p49903]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 544\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent INPP4A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent inositol polyphosphate-4-phosphatase, type 1 isoform b; inositol polyphosphate-4-phosphatase, type i, 107kd; 4-phosphatase i; inositol polyphosphate-4-phosphatase i. [source:refseq;acc:nm\_001566]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 545\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent EIF6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent eukaryotic translation initiation factor 6 (eif-6) (b4 integrin interactor) (cab) (p27(bbp)) (b(2)gcn homolog). [source:swissprot;acc:p56537]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 248.866\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 233.287\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06678\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 546\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent WAS\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent wiskott-aldrich syndrome protein (wasp). [source:swissprot;acc:p42768]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 207.222\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 194.262\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06671\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 547\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent CRK\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent proto-oncogene c-crk (p38) (adapter molecule crk). [source:swissprot;acc:p46108]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 207.26\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 194.346\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.06645\vspace{3pt}}}\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 548\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ABL2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent tyrosine-protein kinase abl2 (ec 2.7.1.112) (tyrosine kinase arg). [source:swissprot;acc:p42684]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 549\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent proto-oncogene tyrosine-protein kinase src (ec 2.7.1.112) (p60-src) (c-src). [source:swissprot;acc:p12931]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 550\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent HCK\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent tyrosine-protein kinase hck (ec 2.7.1.112) (p59-hck/p60-hck) (hemopoietic cell kinase). [source:swissprot;acc:p08631]\vspace{3pt}}&&&\\\cline{1-5} \parbox{\wcA}{\vspace{3pt}\noindent 551\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent GRAP2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent grb2-related adaptor protein 2 (gads protein) (growth factor receptor binding protein) (grblg) (grf40 adaptor protein) (grf-40) (grb-2-like protein) (grb2l) (grbx) (p38) (hematopoietic cell-associated adaptor protein grpl) (adapter protein grid) (sh3-sh2-sh3 adaptor mona). [source:swissprot;acc:o75791]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 207.261\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 194.347\vspace{3pt}}&\\\cline{1-5} \parbox{\wcA}{\vspace{3pt}\noindent 552\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent CRKL\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent crk-like protein. [source:swissprot;acc:p46109]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 207.26\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 194.346\vspace{3pt}}}&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 553\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ABL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent proto-oncogene tyrosine-protein kinase abl1 (ec 2.7.1.112) (p150) (c-abl). [source:swissprot;acc:p00519]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 554\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent FYN\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent proto-oncogene tyrosine-protein kinase fyn (ec 2.7.1.112) (p59-fyn) (syn) (slk). [source:swissprot;acc:p06241]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 555\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent FGR\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent proto-oncogene tyrosine-protein kinase fgr (ec 2.7.1.112) (p55-fgr) (c-fgr). [source:swissprot;acc:p09769]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 556\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent CUTL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent ccaat displacement protein (cdp) (cut-like 1). [source:swissprot;acc:p39880]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 207.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 194.368\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06638\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 557\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent CUTL2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent homeobox protein cux-2 (cut-like 2) (fragment). [source:swissprot;acc:o14529]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 207.272\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 194.371\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06637\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 558\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent ubiquitin activating enzyme e1-like protein. [source:refseq;acc:nm\_006395]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 135.087\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 144.041\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06628\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 559\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent WASL\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent neural wiskott-aldrich syndrome protein (n-wasp). [source:swissprot;acc:o00401]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 207.309\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 194.452\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06612\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 560\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent SOS1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent son of sevenless protein homolog 1 (sos-1). [source:swissprot;acc:q07889]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 205.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 193.021\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06589\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 561\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent SOS2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent son of sevenless protein homolog 2 (sos-2). [source:swissprot;acc:q07890]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 205.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 193.183\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06578\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 562\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent GULP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent ptb domain adaptor protein ced-6; engulfment adapter protein. [source:refseq;acc:nm\_016315]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 220.744\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 207.121\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.06577\vspace{3pt}}}\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 563\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent CAPS\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent calcyphosine. [source:swissprot;acc:q13938]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 564\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent CRNKL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent crooked neck-like protein 1 (crooked neck homolog) (hcrn) (cgi-201) (mstp021). [source:swissprot;acc:q9bzj0]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 565\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ZNF547\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent sedlin. [source:swissprot;acc:o14582]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 129.219\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 121.261\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.06563\vspace{3pt}}}\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 566\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent synbindin (trs23 homolog) (hematopoietic stem/progenitor cell protein 172) (hspc172) (ptd009) (cgi-104). [source:swissprot;acc:q9y296]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 567\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent TRAPPC3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent bet3 homolog. [source:swissprot;acc:o43617]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 568\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent putative pre-mrna splicing factor rna helicase (atp-dependent rna helicase #3) (deah-box protein 16). [source:swissprot;acc:o60231]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 226.3\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 212.38\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.06554\vspace{3pt}}}\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 569\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent GPKOW\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent t54 protein. [source:swissprot;acc:q92917]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 570\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent SFRS11\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent splicing factor arginine/serine-rich 11 (arginine-rich 54 kda nuclear protein) (p54). [source:swissprot;acc:q05519]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 229.709\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 215.631\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06529\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 571\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent MDH2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent malate dehydrogenase, mitochondrial precursor (ec 1.1.1.37). [source:swissprot;acc:p40926]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 238.529\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 254.099\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06528\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 572\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent cbf1 interacting corepressor. [source:refseq;acc:nm\_004882]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 227.86\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 213.945\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.06504\vspace{3pt}}}\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 573\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent GPATCH1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent evolutionarily conserved g-patch domain containing. [source:refseq;acc:nm\_018025]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 574\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent MOBKL3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent preimplantation protein 3; likely ortholog of preimplantation protein 3. [source:refseq;acc:nm\_015387]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 221.807\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 208.264\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.06503\vspace{3pt}}}\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 575\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent DNAJB11\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent dnaj homolog subfamily b member 11 precursor (er-associated dnaj protein 3) (erj3) (er-associated hsp40 co-chaperone) (hdj9) (pwp1- interacting protein 4). [source:swissprot;acc:q9ubs4]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 576\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent dj408b20.3 (novel protein similar to 60s acidic ribosomal protein p2 (rplp2)). [source:sptrembl;acc:q9h5a9]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 235.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 250.419\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.0648\vspace{3pt}}\\\hline nd{longtable}
    Legend:
    - Rank is the rank after comparing the two networks
    - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
    - Hugo is the HGNC identifier if it exists
    - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
    - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
    - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
    - Filtered specifies whether we only included the high confidence microarry measurements or not.

    - http://analysis.yellowcouch.org/